3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Colorectal Neoplasms
57
Carcinoma, Non-Small-Cell Lung
29
Breast Neoplasms
18
Rectal Neoplasms
14
Ovarian Neoplasms
14
Carcinoma, Hepatocellular
10
Neoplasm Metastasis
9
Glioblastoma
9
Colonic Neoplasms
9
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
7
Fallopian Tube Neoplasms
7
Brain Neoplasms
6
Neoplasms
5
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Liver Neoplasms
4
Inflammatory Breast Neoplasms
4
Colorectal Cancer Metastatic
4
Carcinoma, Ovarian Epithelial
4
Stomach Neoplasms
3
Pleural Effusion, Malignant
3
Meningeal Carcinomatosis
3
Melanoma
3
Kidney Neoplasms
3
Glioma
3
Non-squamous Non-small Cell Lung Cancer
2
Liver Metastasis Colon Cancer
2
Interventions
toripalimab
1
Pemetrexed
1
Paclitaxel
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
EGFR Positive Non-small Cell Lung Cancer
×
Bevacizumab
×
Clear all
NCT03126799
2022-04-06
AvaTa
National Cancer Center, Korea
Phase 2
Unknown
128 enrolled